European Marketing Authorization Holder (MAH)

Your Trusted MAH Partner in Europe

A Marketing Authorization Holder (MAH) is the legal entity responsible for obtaining and maintaining the authorization to market a medicinal product across Europe. The MAH ensures compliance with EU/UK regulations, including Good Manufacturing Practices (GMP), pharmacovigilance obligations, supply chain oversight, and quality control. The responsibility for the performance of a medicinal product over its lifetime, its safety, quality and efficacy, lies with the MAH. For pharmaceutical companies without an EU or UK presence, securing an experienced MAH partner is critical to regulatory success.

Speak with an Expert

Why Choose ProPharma?

With over 20 years of experience in commercializing medicinal products, ProPharma has successfully supported pharmaceutical companies worldwide in achieving marketing authorization, achieving reimbursement, and maintaining compliance. We provide:

A trusted partner for all MAH responsibilities, including acting as your MAH

Expert guidance tailored to your specific regulatory and market access needs

Comprehensive support from regulatory submissions to post-market compliance
Proven success in navigating country-specific pricing and reimbursement challenges
EU and UK MIA licenses and WDA support

Partner with ProPharma to simplify your market entry across Europe and ensure long-term compliance. Contact us today to learn more about how we can support your marketing authorization needs.

Speak with an Expert

professionals-pointing-to-laptop-as-914178358

ProPharma's Comprehensive MAH Services

Navigating both the specific country and centralized European regulations and requirements to supply medicinal products to the European markets can be a complex challenge.

With decades of experience, our experts provide a full spectrum of MAH services to support pharmaceutical companies in successfully navigating the regulatory requirements across Europe. Our tailored solutions ensure compliance, streamline market entry, and maintain product integrity.

Regulatory & Compliance Support

Guidance on selecting the optimal regulatory pathway
Full gap analysis, MAA readiness assessment and pre-submission activity support
End-to-end regulatory submissions for marketing authorization applications (Centralized, Decentralized, Mutual Recognition, and National Procedures)
Maintenance of marketing authorizations, including variations and renewals
Dossier preparation and procedural management
Lifecycle management

Pharmacovigilance & Safety Management

PV gap analysis to ensure inspection readiness
Full pharmacovigilance system implementation, including QPPV services
Development and maintenance of the Pharmacovigilance System Master File (PSMF)
Signal detection, case processing and submission, literature search, and risk management planning
Compliance with Good Pharmacovigilance Practices (GVP) requirements
Provision of Local responsible Person for Pharmacovigilance (LPPV), as applicable

Quality & Manufacturing Oversight

EEA/UK GMP compliance support, including Qualified Person (QP) and Responsible Person (RP) services
Batch release and supply chain oversight for seamless product distribution
Manufacturing license (MIA) support and QP declarations
Labelling, packaging, and serialization compliance with EEA/UK standards

Market Access & Commercialization

Strategic support for pricing and reimbursement
Joint Clinical Assessment (JCA) dossier preparation and submission
National Health Technology Assessment (HTA) dossier preparations and submissions
Guidance on selecting the optimal market entry
Competitive landscape analysis and product positioning
Price and reimbursement maintenance, including renewals

Tailored Solutions for Specific Challenges

Pharmaceutical companies—whether generic or biosimilar manufacturers, orphan drug or ATMP (cell and gene) manufacturers, non-EU companies or innovative drug developers—face unique challenges in obtaining EU marketing authorization. We offer specialized solutions to address these hurdles.

Challenges Faced by Non-European Companies & ProPharma Solutions

ProPharma offers comprehensive support by guiding companies through regulatory pathways, conducting gap analyses, facilitating regulatory meetings, ensuring quality compliance, and providing QPPV services. With expertise in pricing strategies and logistics, ProPharma streamlines the EU market entry process for US companies, ensuring regulatory success and commercial viability.

Challenge: Understanding EMA requirements vs. FDA and/or other regional regulations.

Solution: ProPharma provides expert guidance on EEA/UK regulatory frameworks.

Challenge: Adapting US-based clinical data to meet EEA/UK standards.

Solution: ProPharma conducts gap analyses and supports data generation.

Challenge: Engaging effectively with EMA and national authorities.

Solution: ProPharma facilitates pre-submission meetings and regulatory discussions.

Challenge: Aligning with EEA/UK GMP, GDP, and GVP requirements.

Solution: ProPharma assists in quality system implementation and compliance.

Challenge: Setting up a compliant EEA/UK pharmacovigilance system in more than 30 countries.

Solution: ProPharma offers full pharmacovigilance services, including QPPV and LPPV appointment tailored to our clients needs.

Challenge: Navigating European JCA requirements and complex country-specific HTA and reimbursement processes.

Solution: ProPharma prepares JCA dossier for submission on a European level and develops country-specific pricing and reimbursement dossiers for submission.

Challenge: Establishing an efficient and compliant supply chain.

Solution: ProPharma provides MIA and QP declaration support.

Challenges Faced by Generic or Biosimilar Development Companies & ProPharma Solutions

ProPharma provides tailored solutions by offering expert guidance on bioequivalence studies, dossier compliance, and regulatory submissions, as well as comprehensive support for GMP implementation, QPPV services, and pricing strategies. By streamlining the authorization process, ProPharma enables generic and biosimilar development companies to efficiently enter and succeed in the European market.

Challenge: Proving bioequivalence to the Reference Medicinal Product (RMP) requires well-designed studies and robust data analysis.

Solution: ProPharma advises on study design, conducts rigorous data analysis, and ensures EMA compliance for successful bioequivalence demonstration.

Challenge: Selecting the optimal approval pathway can be complex.

Solution: ProPharma provides strategic guidance and application management centralized and across multiple EU member states.

Challenge: Adapting existing data to meet EU regulatory standards.

Solution: ProPharma ensures dossier compliance, including API characterization and stability studies.

Challenge: Variations or withdrawals of the RMP affecting generic approvals.

Solution: ProPharma actively monitors RMP changes and advises on regulatory updates.

Challenge: Ensuring compliance with EEA/UK GMP standards.

Solution: ProPharma supports GMP implementation and quality assurance.

Challenge: Maintaining a compliant pharmacovigilance system.

Solution: ProPharma offers full pharmacovigilance support, including QPPV services and risk management.

Challenge: Navigating country-specific aggressive generic drug price controls and pricing regulations.

Solution: ProPharma provides full competitive pricing analysis followed by reimbursement preparation and submission with price maintenance support.

News & Insights

Thought Leadership Webinars Press Awards Resource Library

January 14, 2026

2025 Year in Review: Regulatory Shake-Ups Reshaping Pharma Promotion in 2026

Explore 2025's FDA enforcement trends, OPDP changes, and evolving guidance shaping pharma advertising, MLR review, and compliance strategies for 2026.

Read Full Article

December 22, 2025

Understanding FDA Requirements for Medical Information Services in the US

Learn about FDA requirements for medical information services in the US and how MI teams ensure compliance and protect public health through proper reporting and documentation practices.

Read Full Article

December 15, 2025

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences ...

Discover the key differences and enhancements between Annex 11 2011 and the 2025 draft version for computerised systems in GMP-regulated environments.

Read Full Article

View all Thought Leadership

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

Read Full Article

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

Read Full Article

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Read Full Article

View all Press

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Read Full Article

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Read Full Article

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Read Full Article

View all Awards

Case Study

December 15, 2025

Overcoming Operational Hurdles in a High-Stakes Stroke Trial

Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This...

Read Full Article

Article

November 24, 2025

Functional Service Provider: An Emerging Paradigm in Clinical Trial Management

As biopharma and device companies face workforce reductions, global site expansion, and increasingly intricate clinical protocols, traditional outsourcing models often fall short. The cost of...

Read Full Article

Article

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Read Full Article

View all Resources

February 17, 2026

Evolving FDA Expectations: How High-Functioning MLR Teams Manage Risk in 2026

With promotional scrutiny increasing around areas such as social media, influencer campaigns, direct-to-consumer (DTC) messaging, and data-driven claims, the session walks through the characteristics...

February 11, 2026

Scaling High-Quality Medical Information Through Offshoring

Navigate the complexities of offshoring Medical Information and explore proven strategies to ensure consistent quality, regulatory compliance, and seamless global execution. Join us for an...

January 20, 2026

Cracking the Code – Successfully Delivering a Technology Transfer Project

In this power-packed webinar, we’ll demystify technology transfer and show why it’s one of the most strategic and risk-sensitive steps in pharmaceutical and biotech operations. You’ll uncover insider...

Watch the Replay

View all Webinars

News & Insights

January 14, 2026

2025 Year in Review: Regulatory Shake-Ups Reshaping Pharma Promotion in 2026

Explore 2025's FDA enforcement trends, OPDP changes, and evolving guidance shaping pharma advertising, MLR review, and compliance strategies for 2026.

Read This Article

December 22, 2025

Understanding FDA Requirements for Medical Information Services in the US

Learn about FDA requirements for medical information services in the US and how MI teams ensure compliance and protect public health through proper reporting and documentation practices.

Read This Article

December 15, 2025

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences ...

Discover the key differences and enhancements between Annex 11 2011 and the 2025 draft version for computerised systems in GMP-regulated environments.

Read This Article

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

Read This Article

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

Read This Article

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Read This Article

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Read This Article

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Read This Article

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Read This Article

Case Study

December 15, 2025

Overcoming Operational Hurdles in a High-Stakes Stroke Trial

Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This...

View This Resource

Article

November 24, 2025

Functional Service Provider: An Emerging Paradigm in Clinical Trial Management

As biopharma and device companies face workforce reductions, global site expansion, and increasingly intricate clinical protocols, traditional outsourcing models often fall short. The cost of...

View This Resource

Article

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

View This Resource

February 17, 2026

Evolving FDA Expectations: How High-Functioning MLR Teams Manage Risk in 2026

February 11, 2026

Scaling High-Quality Medical Information Through Offshoring

Navigate the complexities of offshoring Medical Information and explore proven strategies to ensure consistent quality, regulatory compliance, and seamless global execution. Join us for an...

January 20, 2026

Cracking the Code – Successfully Delivering a Technology Transfer Project

Watch the Replay